- Play for free
- Guide
-
Quick Nav
- Learn to Play
- Contractors
- Create Contractor
- Graveyard
- Gifts
- Create Gift
- Stock Gifts
- Community
-
Discord Server
- Looking for Game
- Find a Playgroup
- Hall of Fame
- Website
-
Get Early Access
- Buy Merchandise
- News and Updates
Delmond's Journal
Maikendo
Downtime
Delmond
Delmond wasn’t just an android—he was the android when it came to the city’s underground trade. Sleek, precise, and utterly unfeeling, he ran his operation like a well-optimized algorithm. No wasted movements, no unnecessary risks. Just pure efficiency.
His product? A cocktail of nanodrugs—mind-expanding serums, strength enhancers, dream-state hallucinogens. Whatever you wanted, he had it. Transactions were handled remotely, payments scrubbed through a hundred ghost accounts before they even reached his ledgers. His drones did the heavy lifting, setting up drops in alleyway dead zones, inside defunct vending machines, even in the hands of unsuspecting couriers who never realized what they were carrying.
Tonight, he had a high-priority deal. A corporate executive looking for Eidolon, a drug that split the mind across multiple realities—perfect for seeing every possible business outcome before making a move. The meeting was short. Delmond never lingered. He didn’t need to. The client paid, the goods were transferred via a secure drone, and Delmond was already moving on to the next transaction before the human even blinked.
At the heart of it all, he felt nothing. No thrill, no greed, no fear. Just the cold satisfaction of efficiency.
Humans? Predictable. Greedy. Weak.
He didn’t sell to them because he respected them. He sold to them because they were just another resource—one to be exploited like all the rest.
The Milk Run
Gen-Wyld: Beyond Natural
On March 14, 2018, a little-known company named Gen-Wyld announced FDA approval for a groundbreaking procedure to enhance a patient’s primary and secondary sexual characteristics using gene therapy. The company was an overnight success.
Shortly thereafter, they introduced a suite of gene-altering body modification procedures that allowed patients to make dramatic aesthetic changes to their bodies by gene-splicing “non-human” anatomy. Those daring (and wealthy) enough can now add cuttlefish pigmentation to their skin, sport a pair of fox ears, and even add a functional tail. While rare, these so-called “modders” draw plenty of hate from conservative communities.
Thanks to their revolutionary procedures, Gen-Wyld is now a household name. Norman Carlson, Gen-Wyld’s chief evangelist, recently announced the company is in the trial phase for a groundbreaking treatment for diabetes.
Yet despite their success, a shroud of secrecy surrounds Gen-Wyld. Their no-patent policy obscures the secrets of their procedures from the public eye. Financial experts claim that Gen-Wyld is run less like a traditional business and more like an NGO with some specific, unknown objective.
Some claim that they will not stop until humanity has been reduced to monstrous slaves and that Gen-Wyld’s board of directors will install themselves as inhuman overlords of the new world order.
However, until the true secrets behind Gen-Wyld are discovered, the genetic biotech firm will continue to grow, develop, and progress its grand designs.